TOP > 外国特許検索 > PREVENTIVE AGENT AND THERAPEUTIC AGENT FOR CATARACTS, AND USE OF HAT INHIBITOR FOR PRODUCTION THEREOF

PREVENTIVE AGENT AND THERAPEUTIC AGENT FOR CATARACTS, AND USE OF HAT INHIBITOR FOR PRODUCTION THEREOF NEW コモンズ

外国特許コード F180009453
整理番号 (FU684)
掲載日 2018年7月25日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2017JP019034
国際公開番号 WO 2018078922
国際出願日 平成29年5月22日(2017.5.22)
国際公開日 平成30年5月3日(2018.5.3)
優先権データ
  • 特願2016-208121 (2016.10.24) JP
発明の名称 (英語) PREVENTIVE AGENT AND THERAPEUTIC AGENT FOR CATARACTS, AND USE OF HAT INHIBITOR FOR PRODUCTION THEREOF NEW コモンズ
発明の概要(英語) Provided are: a novel preventive agent and a novel therapeutic agent for cataracts; and use of an HAT inhibitor for production thereof. The preventive agent or therapeutic agent for cataracts according to the present invention contains an HAT inhibitor as an active ingredient.
特許請求の範囲(英語) [claim1]
1. HAT inhibitor contains as an active ingredient, cataract preventing or treating agent.
[claim2]
2. The HAT, HAT1,NAA60,GCN5,PCAF,TIP60,MOZ,MORF,HBO1,MOF,P300,CBP,TAF1,TIFIIIC90,SRC1,SCR3,P600,CLOCK inhibitor is selected from the group consisting of 1 NAT10 and the one or more materials are targeted, according to claim 1 cataractogenisis preventing or treating agent.
[claim3]
3. The HAT inhibitors, polyphenol derived compound, in the structure and a heterocyclic ring is a compound comprising, benzoic acid derivatives, or α - β unsaturated carbonyl compound, according to claim 1 or 2 cataractogenisis preventing or treating agent.
[claim4]
4. The HAT inhibitors, curcumin, 2,6 - bis (-3 - - bromo - -4 - hydroxy benzylidene malonate) cyclohexane, CTK7A, Epigenetic Multiple Ligand, garcinol, -2 - - chloro - -3 (4-- nitrophenyl) anacardic, MG149,C646,NU9056,CPTH2,5- acid (2H) -isothiazolone, butyrolactone 3, gallic acid, (-) -epigallocatechin, EML425, L002, ISOX DUAL, plumbagin, TH1834,SPV106,Windorphen, ketomin, Remodelin, enberin, Ischemin, CBP30 KG501 and 1 is selected from the group consisting of the one or more materials, or a salt or a derivative or the material, according to claim 1 or 2 cataractogenisis preventing or treating agent.
[claim5]
5. If the dosage is eyedrops, cataract of any one of claims 1-4 1 preventing or treating agent.
[claim6]
6. The above-mentioned Cataracts are, cataract in diabetes, cataract of any one of claims 1-5 1 preventing or treating agent.
[claim7]
7. Preventing or treating a cataractogenisis for manufacture, use of inhibitors of HAT.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • UNIVERSITY OF FUKUI
  • 発明者(英語)
  • OKI MASAYA
  • KANADA FUMITO
  • TAKAMURA YOSHIHIRO
  • MIYAKE SEIJI
  • UCHIDA HIROYUKI
国際特許分類(IPC)
指定国 (WO201878922)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記までご連絡ください。

PAGE TOP

close
close
close
close
close
close